Latest 10-K annual reports

OTC.Pink
SSKN
Strata Skin Sciences, INC
10-K/A: Strata Skin Sciences Files Amended 10-K to Include Part III Information
Strata Skin Sciences files an amendment to its 2024 annual report to include information required by Part III of Form 10-K, covering details about directors, executive compensation, and related matters.
NASDAQ
NRXP
Nrx Pharmaceuticals, INC
10-K/A: NRx Pharmaceuticals Files Amendment to 10-K Report, Providing Updated Information on Directors, Executive Compensation, and Corporate Governance
NRx Pharmaceuticals files an amendment to its 2024 annual report on Form 10-K to update information regarding directors, executive compensation, security ownership, related transactions, and accounting fees.
NASDAQ
HCAT
Health Catalyst, INC
10-K/A: Health Catalyst Files Amendment to 2024 Annual Report on Form 10-K
Health Catalyst files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and accountant fees.
NASDAQ
FWRD
Forward Air CORP
10-K/A: Forward Air Files Amendment No. 3 to 2024 Annual Report on Form 10-K/A
Forward Air Corporation files Amendment No. 3 to its 2024 Annual Report on Form 10-K/A to include previously omitted information regarding directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, and accounting fees.
NASDAQ
FBYD
Falcon's Beyond Global, INC
10-K/A: Falcons Beyond Global Files Amendment to 10-K, Updates Executive and Director Information
Falcons Beyond Global amends its annual report on Form 10-K to update information regarding directors, executive officers, corporate governance, and executive compensation.
NASDAQ
TRAW
Traws Pharma, INC
10-K/A: Traws Pharma Files Amendment to 10-K to Include Omitted Part III Information
Traws Pharma files an amendment to its 2024 annual report to include information previously omitted regarding directors, executive officers, and corporate governance.
NYSE
HHH
Howard Hughes Holdings INC
10-K/A: Howard Hughes Holdings Files Amendment to 2024 Annual Report, Details Executive Compensation and Governance
Howard Hughes Holdings Inc. files an amendment to its 2024 Annual Report on Form 10-K/A to include information required by Items 10 through 14 of Part III, covering details on directors, executive compensation, and corporate governance.
NASDAQ
VTRS
Viatris INC
10-K/A: Viatris Files Amended 10-K, Addressing Executive Compensation and Governance Following Shareholder Feedback
Viatris files an amendment to its 2024 annual report to include Part III information on directors, executive officers, and compensation, responding to shareholder concerns and detailing strategic initiatives.
NASDAQ
OPRT
Oportun Financial CORP
10-K/A: Oportun Financial Corporation Files Amendment to 10-K, Addressing Omitted Information
Oportun Financial Corporation files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.
NASDAQ
KSCP
Knightscope, INC
10-K/A: Knightscope Files Amended 10-K, Updates Executive and Director Information
Knightscope files an amendment to its 2024 annual report to include information on directors, executive officers, compensation, and related matters.
NASDAQ
LMFA
Lm Funding America, INC
10-K/A: LM Funding America Files Amended 10-K to Update Director and Executive Information
LM Funding America amends its annual report on Form 10-K to update information regarding directors, executive officers, compensation, and related matters.
NASDAQ
CNSP
Cns Pharmaceuticals, INC
10-K/A: CNS Pharmaceuticals Files Amendment to 10-K to Include Omitted Part III Information
CNS Pharmaceuticals files an amendment to its 2024 annual report on Form 10-K to include information required by Items 10 through 14 of Part III, which were initially omitted.
NASDAQ
CBAT
Cbak Energy Technology, INC
10-K/A: CBAK Energy Technology Files Amendment to 10-K, Disclosing Executive and Director Information
CBAK Energy Technology files an amendment to its annual report on Form 10-K to disclose information regarding directors, executive officers, and corporate governance.
NASDAQ
SEER
Seer, INC
10-K/A: Seer Inc. Files Amendment to 10-K to Include Part III Information
Seer, Inc. files an amendment to its 2024 annual report to include information required in Part III, related to directors, executive officers, and corporate governance.
NYSE
KORE
Kore Group Holdings, INC
10-K: KORE Group Holdings Faces Challenges Despite Revenue Growth, 10-K Filing Reveals
KORE Group Holdings' 2024 10-K filing highlights revenue growth offset by operating losses and material weaknesses in internal controls.
NYSE
GRND
Grindr INC
10-K/A: Grindr Files Amendment to 10-K to Include Omitted Information on Directors, Executive Compensation and Corporate Governance
Grindr Inc. files an amendment to its 2024 Annual Report on Form 10-K to include information previously omitted regarding directors, executive compensation, and corporate governance.
NASDAQ
TRNR
Interactive Strength, INC
10-K/A: Interactive Strength Inc. Files Amendment No. 1 to Form 10-K/A to Include Omitted Information
Interactive Strength Inc. files an amendment to its annual report to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and accounting fees.
NASDAQ
PLUG
Plug Power INC
10-K/A: Plug Power Files Amendment to 2024 Annual Report, Addressing Executive Compensation and Governance
Plug Power files an amendment to its 2024 Annual Report on Form 10-K to include Part III information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.
NASDAQ
SBC
Sbc Medical Group Holdings INC
10-K/A: SBC Medical Group Holdings Files Amended 10-K, Updates Executive Team and Corporate Governance
SBC Medical Group Holdings files an amendment to its 2024 annual report to include previously omitted information on directors, executive compensation, and corporate governance, while also updating details on a new executive employment agreement.
LAZR
Luminar Technologies, Inc/de
10-K/A: Luminar Technologies Files Amendment to 2024 Annual Report, Addressing Omitted Information and Executive Certifications
Luminar Technologies files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, accounting fees, and executive certifications.
GORV
Lazydays Holdings, INC
10-K/A: Lazydays Holdings Restates 2024 Financials Due to Warrant Liability Error; Faces Going Concern Uncertainty
Lazydays Holdings files an amendment to its 2024 annual report, restating financial statements due to a warrant liability error and addressing concerns about its ability to continue as a going concern.
NASDAQ
RNAZ
Transcode Therapeutics, INC
10-K/A: TransCode Therapeutics Files Amendment to 10-K, Updates Director and Executive Information
TransCode Therapeutics files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, and corporate governance.
NASDAQ
SUNE
Sunation Energy, INC
10-K/A: SUNation Energy Files Amended Annual Report Detailing Executive Compensation, Governance, and Ownership Following Management Changes
SUNation Energy submitted an amended annual report primarily to incorporate details on its directors, executive officers, compensation structures, and corporate governance following recent leadership transitions and financial activities.
NASDAQ
BYFC
Broadway Financial CORP De
10-K/A: Broadway Financial Corporation Files Amendment to 10-K to Include Part III Information
Broadway Financial Corporation files an amendment to its annual report on Form 10-K to include information required by Part III, as the proxy statement for the 2025 Annual Meeting of Stockholders will not be filed within 120 days after the end of the company's 2024 fiscal year.
NASDAQ
WKHS
Workhorse Group INC
10-K/A: Workhorse Group Files Amendment to 10-K, Addressing Proxy Statement Delay and Including Part III Information
Workhorse Group Inc. files an amendment to its 2024 Annual Report on Form 10-K to include Part III information due to an expected delay in filing its 2025 Definitive Proxy Statement.
NASDAQ
GWAV
Greenwave Technology Solutions, INC
10-K/A: Greenwave Technology Solutions Files Amended 10-K, Addressing Omitted Information and Executive Certifications
Greenwave Technology Solutions files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, and updated certifications.
TZUP
Thumzup Media CORP
10-K/A: Thumzup Media Corporation Files Amendment to 10-K, Addressing Omitted Information on Directors, Executive Pay, and Governance
Thumzup Media Corporation files an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, and corporate governance.
NOVA
Sunnova Energy International INC
10-K/A: Sunnova Energy Files Amended 10-K to Include Omitted Information
Sunnova Energy International Inc. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, compensation, and corporate governance.
NASDAQ
DLPN
Dolphin Entertainment, INC
10-K/A: Dolphin Entertainment Files Amended 10-K to Include Part III Information
Dolphin Entertainment files an amendment to its annual report on Form 10-K to include information required by Items 10 through 14 of Part III.
NASDAQ
RKDA
Arcadia Biosciences, INC
10-K/A: Arcadia Biosciences Files Amendment No. 1 to Form 10-K, Providing Detailed Information on Directors, Executive Compensation, and Corporate Governance
Arcadia Biosciences files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.